Effects of a selective inhibitor of type A monoamine oxidase--Lilly 51641--on behavior, sleep and circadian rhythms in depressed and schizophrenic patients.
D000328:Adult; D001519:Behavior / Q000187:drug effects*; D002940:Circadian Rhythm / Q000187:drug effects*; D002986:Clinical Trials as Topic; D003521:Cyclopropanes / Q000494:pharmacology / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D010647:Phenyl Ethers / Q000494:pharmacology / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D012890:Sleep / Q000187:drug effects*
D003521:Cyclopropanes; D008996:Monoamine Oxidase Inhibitors; D010647:Phenyl Ethers; D010919:Placebos